Global Nonerosive Reflux Disease Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Nonerosive Reflux Disease Treatment
    1.2 Classification of Nonerosive Reflux Disease Treatment by Type
        1.2.1 Overview: Global Nonerosive Reflux Disease Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Nonerosive Reflux Disease Treatment Revenue Market Share by Type in 2020
        1.2.3 Proton pump inhibitors
        1.2.4 H2 Receptor Antagonists
        1.2.5 Antacids
        1.2.6 Others
    1.3 Global Nonerosive Reflux Disease Treatment Market by Application
        1.3.1 Overview: Global Nonerosive Reflux Disease Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Retail Pharmacies
        1.3.3 Hospital Pharmacies
        1.3.4 Online Pharmacies
    1.4 Global Nonerosive Reflux Disease Treatment Market Size & Forecast
    1.5 Global Nonerosive Reflux Disease Treatment Market Size and Forecast by Region
        1.5.1 Global Nonerosive Reflux Disease Treatment Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Nonerosive Reflux Disease Treatment Market Size by Region, (2016-2021)
        1.5.3 North America Nonerosive Reflux Disease Treatment Market Size and Prospect (2016-2026)
        1.5.4 Europe Nonerosive Reflux Disease Treatment Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size and Prospect (2016-2026)
        1.5.6 South America Nonerosive Reflux Disease Treatment Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Nonerosive Reflux Disease Treatment Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Nonerosive Reflux Disease Treatment Market Drivers
        1.6.2 Nonerosive Reflux Disease Treatment Market Restraints
        1.6.3 Nonerosive Reflux Disease Treatment Trends Analysis
2 Company Profiles
    2.1 AstraZeneca
        2.1.1 AstraZeneca Details
        2.1.2 AstraZeneca Major Business
        2.1.3 AstraZeneca Nonerosive Reflux Disease Treatment Product and Solutions
        2.1.4 AstraZeneca Nonerosive Reflux Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 AstraZeneca Recent Developments and Future Plans
    2.2 Eisai
        2.2.1 Eisai Details
        2.2.2 Eisai Major Business
        2.2.3 Eisai Nonerosive Reflux Disease Treatment Product and Solutions
        2.2.4 Eisai Nonerosive Reflux Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Eisai Recent Developments and Future Plans
    2.3 GlaxoSmithKline
        2.3.1 GlaxoSmithKline Details
        2.3.2 GlaxoSmithKline Major Business
        2.3.3 GlaxoSmithKline Nonerosive Reflux Disease Treatment Product and Solutions
        2.3.4 GlaxoSmithKline Nonerosive Reflux Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 GlaxoSmithKline Recent Developments and Future Plans
    2.4 Takeda Pharmaceutical
        2.4.1 Takeda Pharmaceutical Details
        2.4.2 Takeda Pharmaceutical Major Business
        2.4.3 Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Product and Solutions
        2.4.4 Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Takeda Pharmaceutical Recent Developments and Future Plans
    2.5 Johnson & Johnson
        2.5.1 Johnson & Johnson Details
        2.5.2 Johnson & Johnson Major Business
        2.5.3 Johnson & Johnson Nonerosive Reflux Disease Treatment Product and Solutions
        2.5.4 Johnson & Johnson Nonerosive Reflux Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Johnson & Johnson Recent Developments and Future Plans
    2.6 Daewoong Pharmaceutical
        2.6.1 Daewoong Pharmaceutical Details
        2.6.2 Daewoong Pharmaceutical Major Business
        2.6.3 Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Product and Solutions
        2.6.4 Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Daewoong Pharmaceutical Recent Developments and Future Plans
    2.7 Ironwood Pharmaceuticals
        2.7.1 Ironwood Pharmaceuticals Details
        2.7.2 Ironwood Pharmaceuticals Major Business
        2.7.3 Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Product and Solutions
        2.7.4 Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Ironwood Pharmaceuticals Recent Developments and Future Plans
    2.8 SRS Pharmaceuticals
        2.8.1 SRS Pharmaceuticals Details
        2.8.2 SRS Pharmaceuticals Major Business
        2.8.3 SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Product and Solutions
        2.8.4 SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 SRS Pharmaceuticals Recent Developments and Future Plans
    2.9 SFJ Pharmaceuticals Group
        2.9.1 SFJ Pharmaceuticals Group Details
        2.9.2 SFJ Pharmaceuticals Group Major Business
        2.9.3 SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Product and Solutions
        2.9.4 SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 SFJ Pharmaceuticals Group Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Nonerosive Reflux Disease Treatment Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Nonerosive Reflux Disease Treatment Players Market Share
        3.2.2 Top 10 Nonerosive Reflux Disease Treatment Players Market Share
        3.2.3 Market Competition Trend
    3.3 Nonerosive Reflux Disease Treatment Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Nonerosive Reflux Disease Treatment Revenue and Market Share by Type (2016-2021)
    4.2 Global Nonerosive Reflux Disease Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Nonerosive Reflux Disease Treatment Revenue Market Share by Application (2016-2021)
    5.2 Nonerosive Reflux Disease Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Nonerosive Reflux Disease Treatment Revenue by Type (2016-2026)
    6.2 North America Nonerosive Reflux Disease Treatment Revenue by Application (2016-2026)
    6.3 North America Nonerosive Reflux Disease Treatment Market Size by Country
        6.3.1 North America Nonerosive Reflux Disease Treatment Revenue by Country (2016-2026)
        6.3.2 United States Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
        6.3.3 Canada Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
        6.3.4 Mexico Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Nonerosive Reflux Disease Treatment Revenue by Type (2016-2026)
    7.2 Europe Nonerosive Reflux Disease Treatment Revenue by Application (2016-2026)
    7.3 Europe Nonerosive Reflux Disease Treatment Market Size by Country
        7.3.1 Europe Nonerosive Reflux Disease Treatment Revenue by Country (2016-2026)
        7.3.2 Germany Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
        7.3.3 France Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
        7.3.5 Russia Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
        7.3.6 Italy Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Nonerosive Reflux Disease Treatment Revenue by Type (2016-2026)
    8.2 Asia-Pacific Nonerosive Reflux Disease Treatment Revenue by Application (2016-2026)
    8.3 Asia-Pacific Nonerosive Reflux Disease Treatment Market Size by Region
        8.3.1 Asia-Pacific Nonerosive Reflux Disease Treatment Revenue by Region (2016-2026)
        8.3.2 China Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
        8.3.3 Japan Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
        8.3.4 South Korea Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
        8.3.5 India Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
        8.3.7 Australia Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Nonerosive Reflux Disease Treatment Revenue by Type (2016-2026)
    9.2 South America Nonerosive Reflux Disease Treatment Revenue by Application (2016-2026)
    9.3 South America Nonerosive Reflux Disease Treatment Market Size by Country
        9.3.1 South America Nonerosive Reflux Disease Treatment Revenue by Country (2016-2026)
        9.3.2 Brazil Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
        9.3.3 Argentina Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Nonerosive Reflux Disease Treatment Revenue by Type (2016-2026)
    10.2 Middle East & Africa Nonerosive Reflux Disease Treatment Revenue by Application (2016-2026)
    10.3 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Country
        10.3.1 Middle East & Africa Nonerosive Reflux Disease Treatment Revenue by Country (2016-2026)
        10.3.2 Turkey Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
        10.3.4 UAE Nonerosive Reflux Disease Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer